Skip to Content

Psychological Distress High Among Students During COVID-19

TUESDAY, Feb. 2, 2021 -- The prevalence of self-reported psychological distress among students has been relatively high during the COVID-19 pandemic, according to a study published online Jan. 26 in JAMA Network Open.

Zuguo Qin, M.P.H., from the Health Publicity and Education Center of Guangdong Province in Guangzhou, China, and colleagues conducted a cross-sectional study using data from a survey of children in Guangdong province, China, to examine self-reported psychological distress associated with COVID-19, measured using the total score on the 12-item General Health Questionnaire. Data were included for 1,199,320 students (mean age, 12.04 years).

The researchers found that 10.5 percent of the students self-reported psychological distress. High school students had an increased risk for psychological distress compared with students in primary school (odds ratio, 1.19). Students who never wore a face mask had an increased risk for psychological distress compared with those who wore a face mask frequently (odds ratio, 2.59). Compared with students who spent more than one hour exercising, those who spent less than 0.5 hours exercising had increased odds of self-reported psychological distress (odds ratio, 1.64).

"Based on these findings, it is necessary for governments, schools, and families to pay attention to the mental health of school-aged children and adolescents during the COVID-19 pandemic and take appropriate countermeasures to reduce the impact of the COVID-19 pandemic on mental health for children and adolescents," the authors write.

Abstract/Full Text

© 2021 HealthDay. All rights reserved.

Posted: February 2021

Read this next

Walmart Expands COVID-19 Vaccination Program

MONDAY, March 1, 2021 -- Walmart said it will expand its COVID-19 vaccination program to more than 1,400 pharmacies in 35 states. The retailer will also partner with local...

AstraZeneca COVID-19 Vaccine Easy to Update in Response to Variants

MONDAY, March 1, 2021 -- A COVID-19 vaccine still awaiting U.S. Food and Drug Administration approval may prove to be a powerful weapon in fighting the pandemic, according to its...

J&J COVID-19 Vaccine Granted Emergency Use Authorization

MONDAY, March 1, 2021 -- The Janssen COVID-19 vaccine received the third emergency use authorization for a vaccine to prevent COVID-19, the U.S. Food and Drug Administration...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.